Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

A passion for learning took her from apartheid South Africa to a beer brewery to becoming a healthcare consultant, all before ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021. "I wish I hadn't done it, ...

The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...